Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 3
R&D Momentum
75/100
Pipeline Velocity
39/100
Trial Completion Rate
88/100
Pipeline Concentration
33/100
Pipeline Freshness
8/100
Strategic Signals
Activity
Last 14 days
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Imaging Biomarkers in Parkinson Disease
Clinical and Physiological Studies of Tremor Syndromes
Natural History Protocol for Movement Disorders
Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia
Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques
In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance Imaging
Phenotype/Genotype Correlations in Movement Disorders
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)